The use of blood tumour markers in the monitoring of metastatic breast cancer unassessable for response to systemic therapy

By Cheung K.L.  

Breast Cancer Research and Treatment, Vol. 67, Iss. 3, 2001-06 ,pp. : 273-278

Springer Publishing Company

Access to resources Recommend Favorite

Use of the metastatic breast cancer progression (MBC-P) questionnaire to assess the value of progression-free survival for women with metastatic breast cancer

By Hurvitz Sara   Lalla Deepa   Crosby Ross   Mathias Susan  

Breast Cancer Research and Treatment, Vol. 142, Iss. 3, 2013-12 ,pp. : 603-609

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of the expression of stem cell markers in human breast cancer reveals a correlation with clinical progression and metastatic disease in ductal carcinoma

By    

Oncology Reports, Vol. 31, Iss. 1, 2014-01 ,pp. : 262-272

Spandidos Publications

Access to resources Recommend Favorite

Stem cell factor affects tumour progression markers in metastatic melanoma cells

By Prignano Francesca   Gerlini Gianni   Salvatori Benedetta   Orlando Claudio   Mazzoli Sandra   Pimpinelli Nicola   Moretti Silvia  

Clinical and Experimental Metastasis, Vol. 23, Iss. 3-4, 2006-06 ,pp. : 177-186

Springer Publishing Company

Access to resources Recommend Favorite

Prolonged time to progression with fulvestrant for metastatic breast cancer

By Mello Celso  

Medical Oncology, Vol. 28, Iss. 2, 2011-06 ,pp. : 416-419

Humana Press, Inc

Access to resources Recommend Favorite